ProShares Ultra Financial Statements From 2010 to 2024
| RXL Etf | USD 48.53 0.09 0.19% |
Check ProShares Ultra financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ProShares Ultra's main balance sheet or income statement drivers, such as , as well as many indicators such as . ProShares financial statements analysis is a perfect complement when working with ProShares Ultra Valuation or Volatility modules.
ProShares |
ProShares Ultra Health ETF Price To Earning Analysis
ProShares Ultra's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current ProShares Ultra Price To Earning | 17.93 X |
Most of ProShares Ultra's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ProShares Ultra Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
ProShares Ultra Price To Earning Component Assessment
Based on the latest financial disclosure, ProShares Ultra Health has a Price To Earning of 17.93 times. This is 224.82% higher than that of the ProShares family and 5.3% lower than that of the Family category. The price to earning for all United States etfs is notably lower than that of the firm.
ProShares Ultra Health Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ProShares Ultra's current stock value. Our valuation model uses many indicators to compare ProShares Ultra value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ProShares Ultra competition to find correlations between indicators driving ProShares Ultra's intrinsic value. More Info.ProShares Ultra Health is rated second largest ETF in price to earning as compared to similar ETFs. It also is rated second largest ETF in price to book as compared to similar ETFs fabricating about 0.17 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for ProShares Ultra Health is roughly 6.00 . Comparative valuation analysis is a catch-all technique that is used if you cannot value ProShares Ultra by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About ProShares Ultra Financial Statements
ProShares Ultra investors utilize fundamental indicators, such as revenue or net income, to predict how ProShares Etf might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the funds investment objective. Ultra Health is traded on NYSEARCA Exchange in the United States.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of ProShares Ultra Correlation against competitors. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
The market value of ProShares Ultra Health is measured differently than its book value, which is the value of ProShares that is recorded on the company's balance sheet. Investors also form their own opinion of ProShares Ultra's value that differs from its market value or its book value, called intrinsic value, which is ProShares Ultra's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProShares Ultra's market value can be influenced by many factors that don't directly affect ProShares Ultra's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProShares Ultra's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProShares Ultra is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProShares Ultra's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.